4.6 Article

O-GlcNAc: a regulatory post-translational modification

期刊

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/S0006-291X(03)00175-X

关键词

O-GlcNAc; post-translational modification; transcription; signal transduction; apoptosis; neurodegeneration; nutrient sensing; diabetes; Alzheimer's disease; glycosylation

资金

  1. NCI NIH HHS [CA42486] Funding Source: Medline
  2. NICHD NIH HHS [HD13563] Funding Source: Medline
  3. NIDDK NIH HHS [DK38418] Funding Source: Medline

向作者/读者索取更多资源

beta-N-Acetylglucosamine (O-GlcNAc) is a regulatory post-translational modification of nuclear and cytosolic proteins. The enzymes for its addition and removal have recently been cloned and partially characterized. While only about 80 mammalian proteins have been identified to date that carry this modification, it is clear that this represents just a small percentage of the modified proteins. O-GlcNAc has all the properties of a regulatory modification including being dynamic and inducible. The modification appears to modulate transcriptional and signal transduction events. There are also accruing data that O-GlcNAc plays a role in apoptosis and neurodegeneration. A working model is emerging that O-GlcNAc serves as a metabolic sensor that attenuates a cell's response to extracellular stimuli based on the energy state of the cell. In this review, we will focus on the enzymes that add/remove O-GlcNAc, the functional impact of O-GlcNAc modification, and the current working model for O-GlcNAc as a nutrient sensor. (C) 2003 Published by Elsevier Science (USA).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据